Receiver operating characteristic analysis showed that the area under the curve (AUC) of plasma cfDNA and serum AFP levels was 0.89 and 0.86, respectively, and the combined plasma cfDNA and serum AFP levels increased the ability to distinguish HCC patients from CH patients (AUC = 0.96) (Figure 1C). The gene discussed is AFP; the disease is hepatocellular carcinoma.